Loading…
Loading…
EQUITY / NASDAQ · XNCM
Haoxi Health Technology Limited Class A Ordinary Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →07/01/2024 – 06/30/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗2.7 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 2.7 USD · Volume 25,411
21 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
07/01/2024 – 06/30/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 537,646 USD | 1,185,130 USD | -54.63% |
| Operating profit | -1,999,903 USD | 1,717,248 USD | -216.46% |
| Net income | 3,876,680 USD | 1,291,667 USD | +200.13% |
| Operating cash flow | -3,358,082 USD | -747,576 USD | — |
| Total liabilities | 4,218,884 USD | 4,234,618 USD | -0.37% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end07/01/2024 – 06/30/2025ConsolidatedUnits · USD | 2024 / Year end07/01/2023 – 06/30/2024ConsolidatedUnits · USD | 2023 / Year end07/01/2022 – 06/30/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Financing cash flowCash flow statement | 8,902,467 USD | 9,323,557 USD | 1,802,568 USD |
| Gross profitIncome statement | 927,750 USD | 2,750,377 USD | 2,062,066 USD |
| Investing cash flowCash flow statement | -3,580,000 USD | -3,129,051 USD | -45,500 USD |
| Net incomeIncome statement | 3,876,680 USD | 1,291,667 USD | 969,752 USD |
| Operating cash flowCash flow statement | -3,358,082 USD | -747,576 USD | -872,132 USD |
| Operating profitIncome statement | -1,999,903 USD | 1,717,248 USD | 1,195,811 USD |
| RevenueIncome statement | 537,646 USD | 1,185,130 USD | 28,229,149 USD |
| Total assetsBalance sheet | 21,595,314 USD | 15,506,573 USD | — |
| Total equityBalance sheet | 17,376,430 USD | 11,271,955 USD | 1,566,505 USD |
| Total liabilitiesBalance sheet | 4,218,884 USD | 4,234,618 USD | — |
| Capital expendituresCash flow statement | — | 55,367 USD | 45,500 USD |
| Report source | Open report ↗ Published: 10/20/2025 | Open report ↗ Published: 10/20/2025 | Open report ↗ Published: 10/20/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.